19.01 USD
+0.35 (+1.88%)
18.97 USD
-0.04 (-0.21%)
ChartMill assigns a Buy % Consensus number of 78% to SMMT. The Buy consensus is the weighted average rating of the current analysts ratings.
Analysts have set a mean price target forecast of 33.08. This target is 74% above the current price.
SMMT was analyzed by 23 analysts. The buy percentage consensus is at 78. So analysts seem to be have mildly positive about SMMT.
In the previous month the buy percentage consensus was at a similar level.
SMMT was analyzed by 23 analysts, which is quite many. So the average rating should be quite meaningful.
Price Target & Forecast
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2025-12-17 | Barclays | Upgrade | Underweight -> Equal-Weight |
| 2025-11-18 | Wolfe Research | Initiate | Peer Perform |
| 2025-10-22 | Guggenheim | Reiterate | Buy -> Buy |
| 2025-10-21 | Barclays | Maintains | Underweight -> Underweight |
| 2025-10-21 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-10-20 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-10-20 | Citigroup | Maintains | Buy -> Buy |
| 2025-09-17 | Barclays | Initiate | Underweight |
| 2025-09-16 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-09-08 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2025-09-08 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-09-04 | Guggenheim | Initiate | Buy |
| 2025-09-03 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-09-02 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-08-27 | HC Wainwright & Co. | Maintains | Buy -> Buy |
| 2025-08-19 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-08-19 | Piper Sandler | Initiate | Neutral |
| 2025-08-15 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-08-12 | Evercore ISI Group | Maintains | Outperform -> Outperform |
| 2025-07-01 | UBS | Initiate | Buy |
| 2025-07-01 | HC Wainwright & Co. | Reiterate | Buy -> Buy |
| 2025-06-11 | Leerink Partners | Initiate | Underperform |
| 2025-06-02 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-05-02 | Goldman Sachs | Maintains | Buy -> Buy |
| 2025-04-28 | JMP Securities | Reiterate | Market Outperform -> Market Outperform |
| 2025-04-25 | Jefferies | Maintains | Buy -> Buy |
| 2025-04-23 | Cantor Fitzgerald | Reiterate | Overweight -> Overweight |
| 2025-03-26 | Citigroup | Upgrade | Neutral -> Buy |
| 2025-03-21 | Cantor Fitzgerald | Initiate | Overweight |
| 2025-03-12 | Evercore ISI Group | Initiate | Outperform |
SUMMIT THERAPEUTICS INC / SMMT FAQ
What do analysts expect the price target to be for SUMMIT THERAPEUTICS INC (SMMT)?
23 analysts have analysed SMMT and the average price target is 33.08 USD. This implies a price increase of 74% is expected in the next year compared to the current price of 19.01.
Can you provide the consensus rating for SUMMIT THERAPEUTICS INC stock?
The consensus rating for SUMMIT THERAPEUTICS INC (SMMT) is 78.2609 / 100 . This indicates that analysts generally have a positive outlook on the stock.
How many analysts cover SUMMIT THERAPEUTICS INC (SMMT) stock?
The number of analysts covering SUMMIT THERAPEUTICS INC (SMMT) is 23.